• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Update on tumor cell procoagulant factors.

作者信息

Gale A J, Gordon S G

机构信息

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA., USA.

出版信息

Acta Haematol. 2001;106(1-2):25-32. doi: 10.1159/000046586.

DOI:10.1159/000046586
PMID:11549774
Abstract

Tumor cells produce tissue factor, cancer procoagulant, plasminogen activators and other factors that interact with the coagulation system, the fibrinolytic system and vascular or blood cells such that they can upset the normal homeostasis and balance between activation and inhibition of the coagulation and fibrinolytic systems. These activities play a role in tumor cell growth and metastasis, vascular wall function, and hemostasis. Proteases and their inhibitors are intimately involved in all aspects of the hemostatic, cell proliferation and cellular signalling systems. This review provides a brief examination of recent observations in this complex interaction of cellular and hemostatic factors.

摘要

相似文献

1
Update on tumor cell procoagulant factors.
Acta Haematol. 2001;106(1-2):25-32. doi: 10.1159/000046586.
2
Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation.微粒作为循环中促凝和纤溶活性的循环来源。
Thromb Res. 2012 May;129 Suppl 2:S27-9. doi: 10.1016/j.thromres.2012.02.025. Epub 2012 Mar 16.
3
Tumor cell prothrombotic properties.
Haemostasis. 2001;31 Suppl 1:1-4.
4
Overview of the postulated mechanisms linking cancer and thrombosis.癌症与血栓形成相关假定机制概述。
Pathophysiol Haemost Thromb. 2008;36(3-4):122-30. doi: 10.1159/000175150. Epub 2009 Jan 27.
5
Hemostatic factors in tumor biology.
J Pediatr Hematol Oncol. 2000 May-Jun;22(3):281-7. doi: 10.1097/00043426-200005000-00019.
6
The thrombophilic state in cancer patients.癌症患者的血栓形成倾向状态。
Acta Haematol. 2001;106(1-2):33-42. doi: 10.1159/000046587.
7
Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.凝血机制与癌症:对血栓形成和肿瘤进展的影响
Clin Adv Hematol Oncol. 2003 Nov;1(11):673-8.
8
From Virchow's triad to metastasis: circulating hemostatic factors as predictors of risk for metastasis in solid tumors.从魏尔啸三联征到转移:循环止血因子作为实体瘤转移风险的预测指标
J BUON. 2013 Jan-Mar;18(1):25-33.
9
Activation of clotting factors in cancer.癌症中凝血因子的激活
Cancer Treat Res. 2009;148:31-41. doi: 10.1007/978-0-387-79962-9_3.
10
The role of procoagulants and anticoagulants in the development of venous thromboembolism.促凝血剂和抗凝血剂在静脉血栓栓塞形成中的作用。
Thromb Res. 2009;123 Suppl 4:S41-5. doi: 10.1016/S0049-3848(09)70142-2.

引用本文的文献

1
Clinical association between coagulation indicators and bone metastasis in patients with gastric cancer.胃癌患者凝血指标与骨转移之间的临床关联
World J Gastrointest Oncol. 2023 Jul 15;15(7):1253-1261. doi: 10.4251/wjgo.v15.i7.1253.
2
Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study.血栓预防能否为接受手术和/或化疗治疗的癌症患者建立联系?MeTHOS 队列研究。
Support Care Cancer. 2022 Aug;30(8):6973-6984. doi: 10.1007/s00520-022-07096-1. Epub 2022 May 12.
3
Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa.
不同淋巴瘤亚组的凝血酶生成谱及其被andexanet alfa 增强。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620983466. doi: 10.1177/1076029620983466.
4
Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism.癌症患者偶然发生肺栓塞时伴发的深静脉血栓形成的预后意义
Cancers (Basel). 2020 Aug 13;12(8):2267. doi: 10.3390/cancers12082267.
5
Predictive Factors of Deep Vein Thrombosis in Gynecologic Cancer Survivors with Lower Extremity Edema: A Single-Center and Retrospective Study.伴有下肢水肿的妇科癌症幸存者深静脉血栓形成的预测因素:一项单中心回顾性研究
Healthcare (Basel). 2020 Feb 27;8(1):48. doi: 10.3390/healthcare8010048.
6
Altered fibrin clot properties in advanced lung cancer: strong impact of cigarette smoking.晚期肺癌患者纤维蛋白凝块特性的改变:吸烟的强烈影响。
Med Oncol. 2019 Mar 19;36(4):37. doi: 10.1007/s12032-019-1262-4.
7
Lung Cancer and Pulmonary Embolism: What Is the Relationship? A Review.肺癌与肺栓塞:关系如何?综述
J Cancer. 2018 Aug 6;9(17):3046-3057. doi: 10.7150/jca.26008. eCollection 2018.
8
Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.血小板作为肿瘤转移的关键伙伴:从机制层面到药物靶向治疗
Cell Mol Life Sci. 2017 Oct;74(19):3491-3507. doi: 10.1007/s00018-017-2536-7. Epub 2017 May 9.
9
D-dimer measured at first venous thromboembolism is associated with future risk of cancer.首次静脉血栓栓塞时检测的D-二聚体与未来患癌风险相关。
Haematologica. 2016 Dec;101(12):e473-e475. doi: 10.3324/haematol.2016.151712. Epub 2016 Sep 9.
10
LUNG CANCER AND PULMONARY THROMBOEMBOLISM.肺癌与肺血栓栓塞症
Mater Sociomed. 2015 Oct;27(5):351-3. doi: 10.5455/msm.2015.27.351-353. Epub 2015 Oct 5.